S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
NASDAQ:VIVE

Viveve Medical - VIVE Stock Forecast, Price & News

$0.80
-0.02 (-2.44%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.74
$0.84
50-Day Range
$0.61
$0.88
52-Week Range
$0.59
$3.08
Volume
53,698 shs
Average Volume
53,457 shs
Market Capitalization
$8.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

Viveve Medical MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
556.3% Upside
$5.25 Price Target
Short Interest
Healthy
0.48% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.53mentions of Viveve Medical in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.66) to ($1.68) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.72 out of 5 stars

VIVE stock logo

About Viveve Medical (NASDAQ:VIVE) Stock

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Viveve Medical Stock Performance

NASDAQ:VIVE traded down $0.02 during midday trading on Friday, reaching $0.80. The stock had a trading volume of 53,698 shares, compared to its average volume of 53,457. Viveve Medical has a 1-year low of $0.59 and a 1-year high of $3.08. The firm's fifty day simple moving average is $0.70 and its 200-day simple moving average is $0.85.

Viveve Medical (NASDAQ:VIVE - Get Rating) last posted its quarterly earnings results on Thursday, May 12th. The company reported ($0.67) earnings per share (EPS) for the quarter. The company had revenue of $1.64 million during the quarter. Viveve Medical had a negative return on equity of 165.42% and a negative net margin of 371.96%. On average, sell-side analysts anticipate that Viveve Medical will post -2.66 EPS for the current year.

Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

VIVE Stock News Headlines

Viveve Medical (VIVE) to Release Quarterly Earnings on Thursday
Viveve Medical Inc Stock Quote VIVE
Viveve Medical Inc - Stock News
Viveve Medical FY 2021 Earnings Preview
Recap: Viveve Medical Q4 Earnings
Here's what Wall Street expects from Viveve Medical's earnings report
Earnings Preview For Viveve Medical
See More Headlines
Receive VIVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

VIVE Company Calendar

Last Earnings
11/11/2021
Today
8/14/2022
Next Earnings (Estimated)
11/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VIVE
Previous Symbol
OTCMKTS:PLCSD
Employees
47
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.25
High Stock Price Forecast
$5.25
Low Stock Price Forecast
$5.25
Forecasted Upside/Downside
+556.3%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-22,030,000.00
Net Margins
-371.96%
Pretax Margin
-329.76%

Debt

Sales & Book Value

Annual Sales
$6.43 million
Book Value
$1.42 per share

Miscellaneous

Free Float
10,031,000
Market Cap
$8.51 million
Optionable
Optionable
Beta
0.63

Key Executives

  • Mr. Scott C. Durbin (Age 53)
    CEO & Director
    Comp: $719.05k
  • Mr. Jim B. Robbins (Age 58)
    Sr. VP of Fin. & Admin. and Principal Accounting & Financial Officer
    Comp: $386.94k
  • Ms. Deborah Ann Jorn M.B.A. (Age 64)
    Sr. Advisor to the CEO & Director
    Comp: $35k
  • Mr. Martin Kerber P.E.
    VP of Research, Devel. & Operations
  • Ms. Jeannie Swindle
    Sr. Director of Corp. Communications
  • Mr. Jeff Sinclair
    VP of International Sales
  • Mr. Gary Kaiser
    VP of Global Marketing
  • Ms. Lori McMillan
    VP of HR
  • Ms. Suzon D. Lommel (Age 64)
    Sr. VP of Regulatory & Quality Affairs













VIVE Stock - Frequently Asked Questions

What is Viveve Medical's stock price forecast for 2022?

0 analysts have issued twelve-month target prices for Viveve Medical's stock. Their VIVE share price forecasts range from $5.25 to $5.25. On average, they anticipate the company's share price to reach $5.25 in the next twelve months. This suggests a possible upside of 556.3% from the stock's current price.
View analysts price targets for VIVE
or view top-rated stocks among Wall Street analysts.

How have VIVE shares performed in 2022?

Viveve Medical's stock was trading at $1.14 at the start of the year. Since then, VIVE shares have decreased by 29.8% and is now trading at $0.7999.
View the best growth stocks for 2022 here
.

When is Viveve Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 10th 2022.
View our VIVE earnings forecast
.

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) issued its earnings results on Thursday, November, 11th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.58) by $0.09. The business earned $1.62 million during the quarter. Viveve Medical had a negative trailing twelve-month return on equity of 165.42% and a negative net margin of 371.96%. During the same period in the previous year, the company posted ($2.60) earnings per share.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

When did Viveve Medical IPO?

(VIVE) raised $13 million in an initial public offering on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

What is Viveve Medical's stock symbol?

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

How do I buy shares of Viveve Medical?

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Viveve Medical's stock price today?

One share of VIVE stock can currently be purchased for approximately $0.80.

How much money does Viveve Medical make?

Viveve Medical (NASDAQ:VIVE) has a market capitalization of $8.51 million and generates $6.43 million in revenue each year. The company earns $-22,030,000.00 in net income (profit) each year or ($2.73) on an earnings per share basis.

How can I contact Viveve Medical?

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The official website for the company is www.viveve.com. The company can be reached via phone at (720) 696-8100, via email at ir@viveve.com, or via fax at 720-696-8199.

This page (NASDAQ:VIVE) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.